OPY Forecast



Bearish   ↔   Bullish



80% Confidence




Bullish Case: OPY at $86.02 now trades at 0.7x book with record $59.6B AUM intact, rising advisory fees, and a 17-20% one-day plunge already absorbing the Q3 miss (75% net income drop, ECM -82%). Helium's forward PDF peaks at $100-110 with a fat secondary lobe near $105, and Helium's +5.4% drift edge plus mean-reverting historical return surface suggest the selloff over-discounts Q4 capital-markets normalization.




Bearish Case: The Q3 deterioration is structural, not a one-off: Capital Markets swung to a $9.9M loss, equity underwriting fell 82%, and election/rate caution could suppress deal flow into 2027. The backwardated OPY term structure (50%+ IV at 90/85-strikes into 11/20) and Helium's fat lower-tail mass to $65-85 show crash pricing persists; a P/B of 0.7 can reflect deservedly depressed earnings power, not cheapness.




Potential Outcomes:
  1. 42% Stabilization/rebound: $86-100 into Feb on mean-reversion (Helium PDF peak $100-110, +5.4% drift, 0.7 P/B). Fail if spot <$82.
  2. 25% Prolonged stagnation: $78-92 as ECM stays frozen; 11/20 ATM IV stays 48-55%. Matches post-shock lull pattern.
  3. 18% Second leg down: $65-78 on Q4 miss, guidance cut, or SPY risk-off (backwardated put skew + Helium lower-tail mass at 65-85). Fail if no new negative disclosure by 12/18.
  4. 10% Recovery rally >$105: deal-flow restart, rate clarity, IV compression on the 3/19/27 curve (39.6% ATM).
  5. 5% Re-rating >$120: M&A/strategic catalyst; deep-OTM call IVs at 100-160% show tiny market-implied odds.



October 31, 2026















See risk, trade-offs, and measured results before you decide.